Johnson & Johnson, AbbVie and other large pharmaceutical companies on Sunday unveiled research showing that their drugs can improve the prospects of patients suffering from the deadliest forms of cancer, generating excitement at the world’s largest meeting of oncologists.
About 35,000 doctors and scientists gathered in Chicago at the weekend for the annual meeting of the American Society of Clinical Oncology (Asco), where the results of more than 5,000 clinical trials were published.
The data from some studies fuelled hopes that drugmakers are on the cusp of a breakthrough in treating patients who have run out of options.
您已閱讀23%（630字），剩餘77%（2142字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。